ESC 365 - Epidemiology, phenotypes and prognostic impact of secondary mitral regurgitation: current landscape

HFA Premium Access

Epidemiology, phenotypes and prognostic impact of secondary mitral regurgitation: current landscape

Session: Heart failure and secondary mitral regurgitation: new therapeutic strategies

Topic: Mitral Valve Regurgitation

Speaker: Doctor C. Chrysohoou (Athens, GR)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Christina Chrysohoou

National & Kapodistrian University of Athens, Athens (Greece)

17 presentations

2 followers

3 more presentations in this session

Recent trials in secondary mitral regurgitation

Speaker: Professor P. Jhund (Glasgow, GB)

Treatment of 'non-COAPT-like' patients and patients with atrial secondary mitral regurgitation: uncharted territory?

Speaker: Associate Professor M. Adamo (Brescia, IT)

Heart failure and secondary mitral regurgitation: new therapeutic strategies - discussion

Access the full session

Heart failure and secondary mitral regurgitation: new therapeutic strategies

Speakers: Doctor C. Chrysohoou, Professor P. Jhund, Associate Professor M. Adamo

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources